Charles River Labs Intl buy Bank of America Co.
Start price
15.12.25
/
50%
€168.60
Target price
15.12.26
€191.66
Performance (%)
-10.94%
Price
16.04.26
€150.15
Summary
This prediction is currently active. The price of Charles River Labs Intl has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.94%. This prediction currently runs until 15.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | 2.632% | 2.632% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $225.00 price target on the stock.
Ratings data for CRL provided by MarketBeat